FORM 8-A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934
MEDCO RESEARCH, INC.
--------------------
(Exact name of registrant as specified in its charter)
Delaware 95-3318451
- --------------------------------------------------------------------------------
(State of incorporation or organization) (I.R.S. Employer
Identification No.)
7001 Weston Parkway, Cary, North Carolina 27513
- ---------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
Name of each exchange
Title of each class on which each class is
to be so registered to be registered
------------------- ----------------
Common Stock, par value $.001 New York Stock Exchange
Securities to be registered pursuant to Section 12(g) of the Act:
None
----------------
(Title of Class)
<PAGE>
Item 1. Description of Registrant's Securities to be Registered
Common Stock, $.001 Par Value
The capital stock of Medco Research, Inc. (the "Company" or
"Registrant") to be registered on the New York Stock Exchange, Inc. is the
Registrant's Common Stock with a par value of $.001 per share. Holders of the
Common Stock are entitled to one vote per share at all meetings of stockholders.
Dividends that may be declared on the Common Stock will be paid in an equal
amount to the holder of each share of such Stock. No pre-emptive rights are
conferred upon the holders of such Stock and there are no liquidation or
conversion rights. Nor are there any redemption or sinking fund provisions, and
there is no liability to further calls or to assessments by the Registrant.
Item 2. Exhibits
1. All exhibits required by Instruction II to Item 2 will be supplied
to the New York Stock Exchange, Inc.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this registration statement to be signed on
its behalf by the undersigned, thereto duly authorized.
MEDCO RESEARCH, INC.
Date: November 23, 1998 /s/ Glenn Andrews
------------------------------
Name: Glenn Andrews
Title: Chief Financial Officer
Vice President-Finance
& Administration
2
